Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eiber

Showing results (141-150 of 377) with videos related to

Pageof 38
Sort By:
Nuklearmedizin. Nuclear Medicine|February 2, 2021
[PSMA radioligand therapy could pose infrastructural challenges for nuclear medicine: results of a basic calculation for the capacity planning of nuclear medicine beds in the German hospital sector]Claus Zippel, Frederik L Giesel, Clemens Kratochwil, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2018
Early Experience of Rechallenge <sup>177</sup>Lu-PSMA Radioligand Therapy After an Initial Good Response in Patients with Advanced Prostate CancerAndrei Gafita, Isabel Rauscher, Margitta Retz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 11, 2012
Workflow and scan protocol considerations for integrated whole-body PET/MRI in oncologyAxel Martinez-Möller, Matthias Eiber, Stephan G Nekolla, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 2022
Prognostic Role of <sup>68</sup>Ga-PSMA11 PET-Based Response in Patients with Prostate Cancer Undergoing Taxane-Based ChemotherapyLukas Lunger, Maythinee Chantadisai, Amir Karimzadeh, et al.
The Lancet. Oncology|November 2, 2019
What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' replyJeremie Calais, Francesco Ceci, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 8, 2025
AI lesion tracking in PET/CT imaging: a proposal for a Siamese-based CNN pipeline applied to PSMA PET/CT scansStefan P Hein, Manuel Schultheiss, Andrei Gafita, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2021
Performance of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy-a multi-centre evaluation of 2533 patientsAli Afshar-Oromieh, Marcelo Livorsi da Cunha, Jairo Wagner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2021
The Influence of Specific Activity on the Biodistribution of <sup>18</sup>F-rhPSMA-7.3: A Retrospective Analysis of Clinical PET DataThomas Langbein, Alexander Wurzer, Andrei Gafita, et al.
Anticancer Research|September 27, 2015
Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical ProstatectomyMark Thalgott, Brigitte Rack, Thomas Horn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 26, 2018
One-Stop-Shop Whole-Body <sup>68</sup>Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate CancerMark Thalgott, Charlotte Düwel, Isabel Rauscher, et al.
Pageof 38

Showing results (141-150 of 377) with videos related to

Sort By:
Pageof 38
Nuklearmedizin. Nuclear Medicine|February 2, 2021
[PSMA radioligand therapy could pose infrastructural challenges for nuclear medicine: results of a basic calculation for the capacity planning of nuclear medicine beds in the German hospital sector]Claus Zippel, Frederik L Giesel, Clemens Kratochwil, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2018
Early Experience of Rechallenge <sup>177</sup>Lu-PSMA Radioligand Therapy After an Initial Good Response in Patients with Advanced Prostate CancerAndrei Gafita, Isabel Rauscher, Margitta Retz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 11, 2012
Workflow and scan protocol considerations for integrated whole-body PET/MRI in oncologyAxel Martinez-Möller, Matthias Eiber, Stephan G Nekolla, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 29, 2022
Prognostic Role of <sup>68</sup>Ga-PSMA11 PET-Based Response in Patients with Prostate Cancer Undergoing Taxane-Based ChemotherapyLukas Lunger, Maythinee Chantadisai, Amir Karimzadeh, et al.
The Lancet. Oncology|November 2, 2019
What is the best PET target for early biochemical recurrence of prostate cancer?-Authors' replyJeremie Calais, Francesco Ceci, Matthias Eiber, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 8, 2025
AI lesion tracking in PET/CT imaging: a proposal for a Siamese-based CNN pipeline applied to PSMA PET/CT scansStefan P Hein, Manuel Schultheiss, Andrei Gafita, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 5, 2021
Performance of [<sup>68</sup>Ga]Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer after prostatectomy-a multi-centre evaluation of 2533 patientsAli Afshar-Oromieh, Marcelo Livorsi da Cunha, Jairo Wagner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 13, 2021
The Influence of Specific Activity on the Biodistribution of <sup>18</sup>F-rhPSMA-7.3: A Retrospective Analysis of Clinical PET DataThomas Langbein, Alexander Wurzer, Andrei Gafita, et al.
Anticancer Research|September 27, 2015
Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical ProstatectomyMark Thalgott, Brigitte Rack, Thomas Horn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 26, 2018
One-Stop-Shop Whole-Body <sup>68</sup>Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate CancerMark Thalgott, Charlotte Düwel, Isabel Rauscher, et al.
Pageof 38